Member Info for Newboy58

haha, cheers Magsy18

my biggest error this year was buying this fckr at £1.52, what was I thinking just after a .8p placing.... I went in heavy as well, caught up in the hype and hoping for strong sales news as it seemed a fantastic product, gutted tbh, I need a 50% rise to break even....

Better get good sales news this month, as promised

I hope so, this will be BOOM TIME.as soon as that design freeze drops!!!!!!

Elon I thought you were a massive ramper, i'm confused?

Hi badshah13, not really massive news is it? Just the intention of a JV? It's good news and shows the company is totally going in the right direction but it needs everything, planning, developing, paying for. ...

defo going in the right direction..Good long term hold imo

That simply takes the ****

You got to laugh, all that and it just gets massively sold into due to the 40p placing... Should move up when the 20%ers have cleared

Still long term this is now massively de-risked...

Hmm LB28, were you waiting for closer to 40p before jumping back in??

No, it doesn't. Protectionism is so last year.. it's about building a decent product that there is a need for and selling it, ask Tesla who open sourced all their IP btw and just became the highest value car company in the world.

AquaeSulis01 you are wrong on both points. Africa has a lower death rate as the population is younger and fitter, look at the US, cases going up, deaths going down as the protect the vulnerable....

He said based on similar viruses antibodies will protect for 2 years... Of course this can't be proven 100% for at least 2 years but we can't wait that long...

And now we know truffle, from the horse's mouth so to speak.. Skin works in a collaborative / interdependent way.

Personally this works for me rather than the company spending millions trying to reinvent something that they can buy off the shelf so to speak...

I'd give up if I was you GB, I don't think trufflehound will ever get it....

Maybe is should add the daily number of deaths going down, not the cumulative obvs....

The good thing is the number of deaths going down... as treatment gets better the virus gets a lot less scary... Testing will be needed for a long time, it's going no where but we seem to be getting better at treatment...

https://www.worldometers.info/coronavirus/country/us/

Great guy to listen to btw, I really enjoy his interviews

I'm with you there expatbrat, I jumped in yesterday at 6.3 but not too much of an investment. To me it seems there are two main types of AIM share. One that will use dilution as a means to an end, to grow the initial business before they go commercial. There are a few successful ones, ASOS, AUG etc, usually the management have a lot of skin in the game.

Then there are the companies that think they are running a science experiment and will dilute as much as humanly possible, UKOG, KDNC etc.. lots of lost money with these people as every time it starts to look good they dilute.

The Jury is still out for me on what type of company Velocys is. gla

I'll second that Gerard, it's refreshing to be invested in a company with a clear vision, with a CEO who is passionate and isn't afraid to communicate clearly with share holders. Like you say there are traders and long term shareholders and each have their own strategy. For me Integumen feels like a great long term company to invest in. Keep up the great work, it is appreciated. ATB

I made a big error buying back in at 1.58, I've been in AIM long enough to know it would head back closer to the placing price, felt today it was heading for £1 but happily it turned back.... I honestly thought it would be bam, bam bam with sales updates but do far it's nada.... Hopefully get something on Monday.. have a nice weekend all!

Is this the same trial? The timescales are way too long, wtf are they doing??

https://metro.co.uk/2020/06/25/what-like-have-nhs-coronavirus-antibody-test-12900429/

Talk about no rush, it's only a pandemic!

"The results from the antibody tests will be compared to the ‘gold-standard’ lab-based blood sample tests and, if the at-home test is found to have a high degree of accuracy, the programme rolled out to 100,000 people later this year.

REACT-2 is due for completion by the end of the summer and the overall results and findings will be published at a later date."

We were in the mail a few weeks ago and it was BS